Get startedLog in
    Picture of Gritstone bio logo

    GRTSQ — Gritstone bio News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Gritstone Bio Look Forward To Initiating Phase 2B Study (Coral-Barda) In Q1 2024

    Picture of Gritstone bio logoGritstone bio
    27/09/2023 21:01
    Sept 27 (Reuters) - Gritstone bio Inc  GRTS.O :
    * GRITSTONE BIO: AWARDED BARDA CONTRACT TO CONDUCT
COMPARATIVE
PHASE 2B STUDY EVALUATING VACCINE CANDIDATE FOR COVID-19 VALUED
AT UP TO $433 MILLION
    * GRITSTONE BIO: PREPARATIONS FOR COMPARATIVE PHASE 2B STUDY
UNDERWAY & EXECUTION OF STUDY TO BE FULLY FUNDED BY BARDA
    * GRITSTONE BIO: LOOK FORWARD TO INITIATING PHASE 2B STUDY
(CORAL-BARDA) IN Q1 2024

Source text for Eikon:  ID: 
Further company coverage:  GRTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Gritstone bio

    See all news